77 related articles for article (PubMed ID: 42612)
1. Beta receptor blockers on ergometric work in hypertensive patients.
Franz IW; Lohmann FW; Rocker I; Kothari P
Indian Heart J; 1979; 31(5):259-62. PubMed ID: 42612
[No Abstract] [Full Text] [Related]
2. [The influence of a long-term cardioselective and noncardioselective beta-receptorblockade on blood pressure, O2-uptake and carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
Franz IW; Lohmann FW
Z Kardiol; 1979 Jul; 68(7):503-9. PubMed ID: 473853
[TBL] [Abstract][Full Text] [Related]
3. [The effect of so-called cardioselective and non-cardioselective beta-receptor blockers on the metabolism during ergometric exercise in hypertensive patients].
Franz IW; Lohmann FW; Koch G; Röcker L
Verh Dtsch Ges Inn Med; 1978; (84):813-6. PubMed ID: 33508
[No Abstract] [Full Text] [Related]
4. [Beta-blockers in the treatment of hypertension in elderly patients].
Lefflerová K; Widimský J; Lupínek Z
Vnitr Lek; 1991 Feb; 37(2):128-34. PubMed ID: 1673577
[TBL] [Abstract][Full Text] [Related]
5. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
[TBL] [Abstract][Full Text] [Related]
6. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
[No Abstract] [Full Text] [Related]
7. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
8. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
Tassy J; Jouve A
Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
[No Abstract] [Full Text] [Related]
9. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients.
Franz IW; Lohmann FW; Koch G
J Cardiovasc Pharmacol; 1980; 2(1):35-44. PubMed ID: 6154203
[No Abstract] [Full Text] [Related]
10. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
11. [Beta-blockaders in the treatment of hypertension in pregnancy].
Kawecka-Jaszcz K; Skoczeń M
Kardiol Pol; 1985; 28(5):334-9. PubMed ID: 2864465
[No Abstract] [Full Text] [Related]
12. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
13. Bopindolol versus metoprolol in hypertension.
Westerman RF; Christensen C; Westheim A; Donker AJ
Eur J Clin Pharmacol; 1986; 31(3):379-80. PubMed ID: 2878814
[No Abstract] [Full Text] [Related]
14. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
Mattioli G; Ricci S; Menozzi A; Teglio V
Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
[No Abstract] [Full Text] [Related]
15. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
Bjerle P; Jacobsson KA; Agert G
Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
[No Abstract] [Full Text] [Related]
17. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
Safar M; Weiss Y; Chau NP; Kheder A; Levenson J; Milliez P
Nouv Presse Med; 1978 Sep; 7(31):2759-60. PubMed ID: 30957
[No Abstract] [Full Text] [Related]
19. Comparative study with Tobanum and Visken in hypertensive patients.
Torma Z; Grubic V; Unyi G
Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
[No Abstract] [Full Text] [Related]
20. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
Frewin DB; Penhall RK; Leonello PP; Clapp RJ
N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
